Proveca Ltd
Maryam Shah is currently the Head of Portfolio Expansion at Proveca Ltd. With extensive experience in research and project management, Maryam previously held positions as a Senior Project Manager at Cura Living Limited and as a Research Technician at the North West Lung Research Centre. Maryam also completed a PhD in quantitative analysis of formulations at The University of Manchester in collaboration with MedImmune. Maryam's educational background includes a Master of Science in Immunology from The University of Manchester.
Proveca Ltd
Proveca Ltd is a pharmaceutical company specialising in identifying, researching and licensing off-patent medicines with unmet priority health care needs, with a focus on the paediatric market. By developing the necessary formulations and clinical data required to obtain a Paediatric Use Marketing Authorisation (PUMA) these drugs will benefit froma period of 10 years' market protection (8 years of data and market protection plus 2 further years of market protection). In addition, where appropriate, Orphan Drug status (Orphan Drug) will be sought which affords a period of 10 years' market exclusivity to run concurrently.Value will be realised through commercialisation of the licensed medicine or an outright sale of the licence to a larger pharmaceutical company.